ME
MediPal Holdings Corporation
MEPDF · OTC
$18.67 +0.00% (+$0.00)
Market Cap ¥590.4B
P/E Ratio 12.64x
Div. Yield 2.30%
ROE 7.26%
Bulios Fair Price
$22.64
21.3% upside
Current Price
$18.67
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MEPDF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
99 /100
Cheap P/E 12.64x
EV/EBITDA 3.45x
P/B 0.92x
Growth
52 /100
Stable EPS growth 13.71%
Rev. growth 3.71%
Book val. growth 5.32%
Profitability
6 /100
Weak Gross margin 6.43%
Net margin 1.21%
FCF margin 0.00%
Quality
36 /100
Average ROIC 4.07%
ROE 7.26%
Asset turnover 2.01x
Debt
94 /100
Low Debt/Equity 0.07x
Current ratio 1.29x
Net debt/EBITDA -2.45x
Stability
84 /100
Stable Beta -0.02x
Rev. volatility 1.97%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MEPDF
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Shuichi Watanabe
Employees
13,024
Headquarters
Tokyo
Upcoming events
29 SEP
Ex-Dividend
Ex-dividend date
29 SEP
Dividend Payment
Payment date
29 OCT
Earnings
Upcoming earnings report
30 MAR
Ex-Dividend
Ex-dividend date
30 MAR
Dividend Payment
Payment date